Inactive Instrument

R1 RCM Inc.

RCM

US77634L1052

Healthcare Facilities & Services

R1 RCM Inc.(NasdaqGS:RCM) dropped from S&P 1000

Published on 11/19/2024 at 18:00

Latest news about R1 RCM Inc.

R1 RCM Inc. Appoints Chris Ricaurte as Chief Financial Officer	Jun. 11	CI
R1 Appoints Dan Bise as Executive Vice President of Corporate Development and Strategy	Jun. 11	CI
R1 RCM Inc. announced that it has received funding from Khosla Ventures, LLC	May. 27	CI
R1 Launches 'R37' an AI Lab to Transform Healthcare Financial Performance in Exclusive Partnership with Palantir	Mar. 14	CI
R1 RCM Inc.(NasdaqGS:RCM) dropped from S&P Global BMI Index	Nov. 19	CI
R1 RCM Inc.(NasdaqGS:RCM) dropped from S&P TMI Index	Nov. 19	CI
R1 RCM Inc.(NasdaqGS:RCM) dropped from S&P Health Care Services Select Industry Index	Nov. 19	CI
R1 RCM Inc.(NasdaqGS:RCM) dropped from S&P 1000	Nov. 19	CI
R1 RCM Inc.(NasdaqGS:RCM) dropped from S&P 400 Health Care	Nov. 19	CI
R1 RCM Inc.(NasdaqGS:RCM) dropped from S&P Composite 1500	Nov. 19	CI
R1 RCM Inc.(NasdaqGS:RCM) dropped from S&P 400	Nov. 19	CI
R1 RCM Inc. Announces Chief Executive Officer Changes	Nov. 19	CI
R1 RCM Acquisition Completed by Investment Funds Affiliated With TowerBrook Capital Partners, Clayton Dubilier & Rice	Nov. 19	MT
R1 RCM Inc.(NasdaqGM:RCM) dropped from NASDAQ Composite Index	Nov. 18	CI
TowerBrook Capital Partners L.P. and Clayton, Dubilier & Rice, LLC completed the acquisition of remaining 70.6% stake in R1 RCM Inc. from New Mountain Capital, L.L.C., Tcp-Asc Achi Series Lllp and others.	Nov. 18	CI
R1 RCM's Q3 Swings to a Net Loss, Revenue Rises	Nov. 05	MT
Tranche Update on R1 RCM Inc.'s Equity Buyback Plan announced on November 2, 2021.	Nov. 05	CI
R1 RCM Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	Nov. 05	CI
R1 RCM Inc. Provides Unaudited Preliminary Financial Guidance for the Fiscal Quarter Ended September 30, 2024	24-10-22	CI
EU Clears Joint Purchase of US Revenue Cycle Management Company R1 RCM	24-09-04	MT
Nasdaq's wild mood swings	24-08-08
Morgan Stanley Downgrades R1 RCM to Equal Weight From Overweight, $14.30 Price Target	24-08-08	MT
Analyst recommendations: Chevron, Fortinet, Hilton, Walt Disney, Hiscox...	24-08-08
Truist Adjusts Price Target on R1 RCM to $14.30 From $16, Maintains Hold Rating	24-08-08	MT
Tranche Update on R1 RCM Inc.'s Equity Buyback Plan announced on November 2, 2021.	24-08-07	CI

R1 RCM Inc. is a provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups. The Companyâs scalable operating models seamlessly complement a healthcare organizationâs infrastructure, driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. The Company delivers solutions to customers through technology, intellectual property (IP), global scale, and operational excellence. Its Intelligent Automation modernizes processes, removes friction, and simplifies revenue cycle management (RCM). Its use of artificial intelligence (AI) in its platform depends on the availability and pricing of equipment and technical infrastructure from third parties, including Microsoft Azure. It serves over 3,700 hospitals, including 93 of the top 100 health systems, and over 30,000 physicians.

Employees

29,650

Sector

Healthcare Facilities & Services

More about the company

R1 RCM Inc.

Equities

RCM

US77634L1052

Healthcare Facilities & Services

R1 RCM Inc.(NasdaqGS:RCM) dropped from S&P 1000

Latest news about R1 RCM Inc.

Chart R1 RCM Inc.

Company Profile